Switch Therapeutics is an emerging biotechnology company pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science, with the goal of treating a range of diseases – affecting the central nervous system and systemic indications – with significant unmet need. The CASi (Conditionally Activated siRNA) platform, the company’s novel gene knockdown approach, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School and City of Hope. CASi combines advantageous properties of both single and double-stranded RNAs in a single molecule, allowing for cell selective RNAi activity. 

Biotechnology

Research

Switch Therapeutics

Switch Therapeutics' headquarters in San Francisco, CA, United States

Dee Datta

Kevin Zhang

Aiden Aceves

Si-Ping Han

Saumya Das

Brandi Simpson

Charles Allerson

Anindya Bhattacharya

Maxine Nelson

Clara Tourino

Joonhee Han

Marina Kovaliov

Don Button

Craig Blanchette

Michael Wolfe

Douglas Fambrough

Dylan Morris

Alicia Irurzun-Lafitte

Description

People (15)

Craig Blanchette

Michael Wolfe

Dee Datta

Don Button

Tony Ortega

Marina Kovaliov

Raquel Hernandez

Joonhee Han

Clara Tourino

Maxine Nelson

Anindya Bhattacharya

Meena S. S.

Si-Ping Han

James Treanor

Clifford Shaw

Jobs